By staff writers

March 1, 2018 -- Medical software developer Densitas has received clearance from the U.S. Food and Drug Administration (FDA) for its machine-learning breast density assessment software, which generates standardized, personalized, automated density reports.

The software is already cleared for clinical use in Australia, Canada, and Europe, according to the firm.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking